CONCENTRIS RESEARCH MANAGEMENT GMBH - Germany 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:> 1000
Total Number of Projects:900-1000
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2017
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:500-600
Total Number of Projects:500-600
Networking Rank (Reputation):400-500
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:700-800
Networking Rank (Reputation):600-700
2013
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:500-600
Total Number of Projects:71
Total Project Funding:500-600
Partner Constancy:58
Project Leadership Index:69
Diversity Index:64
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:> 1000
Total Number of Projects:69
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):900-1000

Ranking timeline:

Project Participation Performance(2011-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 32
As coordinator: 0
As participant: 32
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 0 9.838.840 689.000 1
2022 0 22.982.612 733.125 1
2021 0 22.274.746 1.812.405 4
2020 0 24.205.507 1.748.500 4
2019 0 19.646.000 890.000 2
2018 0 11.605.788 742.026 2
2017 0 41.037.667 1.333.453 5
2016 0 14.079.021 675.000 2
2014 0 16.500.000 1.013.700 3
2013 0 23.193.108 1.159.500 3
2012 0 9.000.000 633.333 2
2011 0 15.000.000 847.838 3
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
STICHTING KATHOLIEKE UNIVERSITEIT11
KING'S COLLEGE LONDON10
ACADEMISCH ZIEKENHUIS GRONINGEN8
UNIVERSITY COLLEGE LONDON7
ZENTRALINSTITUT FUER SEELISCHE GESUNDHEIT6
KAROLINSKA INSTITUTE5
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN5
STICHTING BURO ECNP5
TARTU ULIKOOL5
UNIVERSITAT DE BARCELONA5
UNIVERSITEIT MAASTRICHT5
UNIVERSITY OF BERGEN5
CHARITE UNIVERSITAETSMEDIZIN BERLIN4
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM4
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA4
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT4
PHILIPPS UNIVERSITAET MARBURG4
TECHNISCHE UNIVERSITAET MUENCHEN4
UNIVERSITAET ULM4
UNIVERSITAET ZUERICH4
UNIVERSITAETSKLINIKUM HEIDELBERG4
UNIVERSITY OF AARHUS4
UNIVERSITY OF BOLOGNA4
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS3
BIOTRIAL3
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER3
DRUG TARGET ID BV3
EUROPEAN ASSOCIATION FOR THE STUDYOF THE LIVER3
EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE3
EUROPEAN LIVER PATIENTS ASSOCIATION3
GENOWAY3
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE3
ISLENSK ERFDAGREINING EHF3
ISTITUTO SUPERIORE DI SANITA3
KATHOLIEKE UNIVERSITEIT LEUVEN3
LEIDS UNIVERSITAIR MEDISCH CENTRUM3
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON3
REGION HOVEDSTADEN3
RIJKSUNIVERSITEIT GRONINGEN3
SERVICIO MADRILENO DE SALUD3
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM3
THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK3
UNIVERSITA DEGLI STUDI DI TORINO3
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT3
UNIVERSITY OF DUNDEE3
ADD INFORMATION SERVICES2
BIOTRIAL BIOMETRICS2
BIOTRIAL NEUROSCIENCE2
BIOTRIAL RESEARCH2
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG2
COMMISSARIAT A L'ENERGIE ATOMIQUE2
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER2
CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED MP2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE2
ELI LILLY AND COMPANY LIMITED2
F HOFFMANNLA ROCHE2
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR2
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA2
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III2
GNOME DESIGN2
INSTITUT CATALA DE LA SALUT2
JANSSEN PHARMACEUTICA NV2
KARLSRUHER INSTITUT FUER TECHNOLOGIE2
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN2
MACHINE2LEARN BV2
MARTIN LUTHER UNIVERSITAET HALLE WITTENBERG2
MEDIZINISCHE HOCHSCHULE HANNOVER2
MEDIZINISCHE UNIVERSITAT GRAZ2
MUCKE HERMANN2
NOVARTIS PHARMA2
OREBRO UNIVERSITY2
OSPEDALE PEDIATRICO BAMBINO GESU2
P1VITAL LIMITED2
PFIZER LIMITED2
PSYCHOGENICS INC2
RESEARCH INSTITUTE AG & CO KG2
SBGNEURO2
STICHTING VUMC2
SYDDANSK UNIVERSITET2
TEL AVIV UNIVERSITY2
THE UNIVERSITY OF EDINBURGH2
THE UNIVERSITY OF EXETER2
THE UNIVERSITY OF WARWICK2
UNIVERSITA DEGLI STUDI DI BARI ""ALDO MORO""2
UNIVERSITA DEGLI STUDI DI VERONA2
UNIVERSITAET BERN2
UNIVERSITAETSKLINIKUM ESSEN2
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF2
UNIVERSITATSKLINIKUM BONN2
UNIVERSITY OF ABERDEEN2
UNIVERSITY OF CAMBRIDGE2
UNIVERSITY OF COPENHAGEN2
UNIVERSITY OF HAMBURG2
UNIVERSITY OF HELSINKI2
UNIVERSITY OF LEICESTER2
UNIVERSITY OF NEWCASTLE UPON TYNE2
UNIVERSITY OF OSLO2
3DPHARMXCHANGE BV1
ABBVIE INC1

Constancy:

Total number of partners: 521
Partner loyalty:
Frequent Partner: (> 2 projects): 190
Rare Partner: 331
Frequent / Rare Partner Ratio: 0.57

Project overview:

Start dateProjectacronymrolefundingpartners
2023-01-01PANcreatic CAncer Initial Detection via liquid biopsy PANCAIDparticipant9.838.84019
2022-09-01Precision drug REPurpOsing For EUrope and the world REPO4EUparticipant22.982.61228
2021-06-01Psychiatric Ratings using Intermediate Stratified Markers 2 PRISM 2participant3.980.90618
2021-04-01Management of chronic cardiometabolic disease and treatment discontinuity in adult ADHD patients TIMESPANparticipant5.999.98617
2021-03-01NOVEL TREATMENT OF ACUTE ON CHRONIC LIVER FAILURE USING SYNERGISTIC ACTION OF G-CSF AND TAK-242 A-TANGOparticipant5.999.99914
2021-03-01Get strong to fight childhood cancer: an exercise intervention for children and adolescents undergoing anti-cancer treatment FORTEeparticipant6.293.85516
2020-04-01DECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEMS APPROACHES DECISIONparticipant6.000.00025
2020-01-01Prevention and Remediation of Insulin Multimorbidity in Europe PRIMEparticipant6.000.00023
2020-01-01Gene overdosage and comorbidities during the early lifetime in Down Syndrome GO-DS21participant5.965.96812
2020-01-01Effective combinational treatment of chronic pain in individual patients, by an innovative quantitative systems pharmacology pain relief approach. QSPainReliefparticipant6.239.53910
2019-01-01Privacy preserving federated machine learning and blockchaining for reduced cyber risks in a world of distributed healthcare FeatureCloudparticipant4.646.0009
2019-01-01MICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response MICROB-PREDICTparticipant15.000.00022
2018-04-01Dynamic MOdelling of REsilience DynaMOREparticipant6.069.01513
2018-02-01An in silico-based approach to improve the efficacy and precision of drug REPurpOsing TRIALs for a mechanism-based patient cohort with predominant cerebro-cardiovascular phenotypes REPO-TRIALparticipant5.536.77313
2017-10-01European Quality In Preclinical Data EQIPDparticipant4.495.52330
2017-09-01Effects of Nutrition and Lifestyle on Impulsive, Compulsive, and Externalizing behaviours Eat2beNICEparticipant11.144.56218
2017-01-01RECAP preterm: Research on European Children and Adults born Preterm RECAP pretermparticipant9.713.23021
2017-01-01Early-life stressors and LifeCycle health LIFECYCLEparticipant9.957.60218
2017-01-01DISCOVERER – DISruptive teChnOlogies for VERy low Earth oRbit platforms DISCOVERERparticipant5.726.7509
2016-04-01Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916 PRISMparticipant8.080.00023
2016-01-01Comorbid Conditions of Attention deficit / hyperactivity disorder CoCAparticipant5.999.02117
2014-04-01Personalized diagnosis and treatment of hyperinsulinemic hypoglycaemia caused by beta-cell pathology BETACUREparticipant6.000.00017
2014-03-01Multidisciplinary Approaches to Translational Research In Conduct Syndromes MATRICSparticipant4.500.00019
2014-02-01THE MILESTONE PROJECT: Managing the Link and Strengthening Transition from Child to Adult Mental Health Care MILESTONEparticipant6.000.00012
2013-11-01Integrative Analysis of Gene Functions in Cellular and Animal Models of Pancreatic Cancer CAM-PACparticipant11.193.10814
2013-11-01Aggression subtyping for improved insight and treatment innovation in psychiatric disorders AGGRESSOTYPEparticipant6.000.00023
2013-10-01IMAging GEnetics for MENtal Disorders IMAGEMENDparticipant6.000.00014
2012-11-01"Observational Prolonged Trial In Myotonic dystrophy type 1 to Improve QoL-Standards, a Target Identification Collaboration" OPTIMISTICparticipant3.000.0009
2012-01-01Translational Adolescent and Childhood Therapeutic Interventions in Compulsive Syndromes TACTICSparticipant6.000.00012
2011-12-01European Multicentre Tics in Children Studies EMTICSparticipant6.000.00030
2011-11-01Pharmacogenomic biomarkers as clinical decision making tools for clozapine treatment of schizophrenia CRESTARparticipant6.000.00011
2011-02-01Targeting the tumour microenvironment to improve pancreatic cancer prognosis EPC-TM-Netparticipant3.000.00017